
A weekly publication by the Bureau of Epidemiology
April 13, 2001
"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Jason Glisson, BS, Epi Editorial Assistant
Bureau of Epidemiology Frequent Contributors:
|
Steven Wiersma, MD, MPH, Deputy State Epidemiologist |
Jodi Baldy, MPH, Biological Scientist IV |
|
Ursula E. Bauer, PhD, Chronic Disease Epidemiologist |
Lisa Conti, DVM, MPH, State Public Health Veterinarian |
Regional Epidemiologists:
|
Dolly Katz, PhD, MPH, SE Florida |
Roger Sanderson, RN, MA, SW Florida |
Carina Blackmore, MS Vet. Med., PhD, NE Florida Carina Blackmore, MS Vet. Med., PhD, |
Zuber Mulla, MSPH, Central Florida Carina Blackmore, MS Vet. Med., PhD, |
Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.
The Department of Health has a home on the World Wide Web at
http://www.doh.state.fl.usIn this issue:
1. National Shortage of Adult Td and TT Vaccines and Potential Shortage of DTaP
Vaccine2. Outbreak of Acute Respiratory Febrile Illness Among College Students --
Acapulco, Mexico, March 2001
1. National Shortage of Adult Td and TT Vaccines and Potential Shortage of DTaP Vaccine
Henry T. Janowski, MPH, Chief, Bureau of Immunization
As many of you are aware, there is a national shortage of adult Tetanus and Diphtheria Toxoids (Td) and Tetanus Toxoid (TT) vaccines; and a potential shortage of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) vaccines. The following information is provided to assist you in managing the anticipated supplies of these vaccines, necessary for prophylaxis in wound management.
Attached is a copy of the Notice to Readers: Update on the Supply of Tetanus and Diphtheria Toxoids and of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Morbidity and Mortality Weekly Report (MMWR), March 16, 2001 / Volume 50(10) / Pages 189-190. The Notice to Readers can also be found on the Centers for Disease Control and Prevention’s (CDC) Web site at
http://www.cdc.gov/mmwr//preview/mmwrhtml/mm5010a3.htm.Nationwide Shortage of Adult Td and TT Vaccines:
Aventis Pasteur is now the sole nationwide distributor of Td and TT. They are shipping limited quantities of these vaccines to assure a wide distribution of available doses. While the company is increasing its production, the shortage is not expected to be resolved for 12 to 18 months. Wound care in clinics and hospitals continues to be the priority for Td and TT and this priority will remain in effect until adequate supplies are restored. Clinics and hospitals in need of vaccine for wound care should call Aventis Pasteur at 1-800-VACCINE or 1-800-822-2463.
Potential Nationwide Shortage of DTaP Vaccine:
There is a potential shortage of DTaP to vaccinate all children. On March 7, 2001, the Food and Drug Administration (FDA) approved a newly formulated version of Aventis Pasteur’s Tripedia® in one-dose vials without preservative and with only a trace amount of thimerosal. With approval of this vaccine, the supply of DTaP should gradually improve.
Presently, there is no change in the national policy for the recommended DTaP immunization schedule.
The CDC is working closely with State Health Departments to ensure equitable distribution of available DTaP vaccine. The CDC and the FDA are monitoring the DTaP vaccine supply situation closely and will provide more guidance should significant supply problems occur.
If an insufficient supply of DTaP vaccine does develop, priority should be given to vaccinating infants with the three initial doses of DTaP since pertussis is most severe among children less than one year of age. If rationing becomes necessary, the fourth DTaP dose should be deferred. The CDC is recommending that the fourth dose-and not the fifth dose-be deferred because the preschool booster is important for maintaining immunity against diphtheria, tetanus and pertussis during the early elementary school years. Receipt of a primary series of DTaP confers adequate protection during the second year of life for many children, so the fourth dose is considered to be the safest to temporarily postpone. When adequate DTaP supplies are available, all children who did not receive the fourth DTaP dose should be recalled for vaccination.
If you have any questions regarding this information, please contact your local county health department.
2. Outbreak of Acute Respiratory Febrile Illness Among College Students --- Acapulco, Mexico, March 2001
Steven Wiersma, MD, MPH, Deputy State Epidemiologist
An outbreak, believed to be due to histoplasmosis, has been identified among travelers to Acapulco, Mexico. A case is defined as an acute respiratory febrile illness characterized by fever for at least 3 days and one or more of the following symptoms: cough, shortness of breath, chest pain, or headache in a student who visited Acapulco during March 2001. A MMWR describing details is available at <http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5014a1.htm>. At this time, one Florida case is under investigation. We encourage readers to get the word out to health care providers that see college students and other travelers. If you identify a potential case, please call Dr. Steven Wiersma at telephone (850) 245-4411, SunCom 205-4411, or email
Steven_Wiersma@doh.state.fl.us for information on testing and reporting.
By Dr. Lisa Conti, State Public Health Veterinarian
Animal Rabies Up for the First Quarter of 2001
Compared with the first quarter (Q1) in 2000, reported animal rabies increased more than 50% during Q1 2001. This was largely due to an epizootic in Seminole County with 10 of the 49 rabid animals reported January through March 2001. Nineteen additional counties reported from one to four animals. During Q1 2000, 32 animals were reported -- Polk County reported 5 and 17 additional counties reported from 1 to 3 rabid animals.
|
Rabid Animal |
Q1 2001 Number % |
Q1 2000 Number % |
||
|
Raccoon |
34 |
69 |
27 |
84 |
|
Cat |
7 |
14 |
1 |
3 |
|
Fox |
6 |
12 |
1 |
3 |
|
Bat |
1 |
2 |
1 |
3 |
|
Horse |
1 |
2 |
||
|
Otter |
1 |
3 |
||
|
TOTAL |
49 |
100 |
32 |
100 |
Of the seven cats reported during Q1 2001, all were reported with neurologic signs including "extreme aggressiveness" and "sick, injured kitten." Five were pet cats and only one was vaccinated against rabies; however, this adult cat was found as a stray and administered vaccine for the first time less than one month prior to its onset of neurologic signs. Three of the cats were from Duval County; and one each from Clay, Martin, Lee and Broward counties. The Q1 2001 rabid horse was reported from Seminole County. It was unvaccinated against rabies and was maintained in a paddock with several other horses and goats, all of which required 180-days quarantine after the rabies diagnosis. State regulations require vaccination of all dogs, cats and ferrets and recommend vaccination of horses against rabies.
PEP Reporting a Useful Tool for Rabies Program Evaluation
Animal bites and other potential rabies exposures are required to be reported to the counties. Among these reports, since October 2000 county health departments have been submitting information on people for whom rabies postexposure prophylaxis (PEP) was given or recommended, and on monkey bites. The former provides important rabies program evaluation information for local and state use and the latter to aid with determining if herpes B testing is indicated.
In a few short months of reviewing rabies PEP forms, several lessons have been learned. We would like to regularly highlight such informative cases to stimulate further dialogue with the objective of identifying useful strategies for program improvement.
The Emergency Department (ED) that is Quick with the Needle
Several counties have encountered the situation where the ED has begun PEP for a dog- or cat-bite victim when the animal was locatable for a 10-day observation period. Reasons for this include:
County health department strategies for improving this situation include: providing rabies training in-services for their ED; requiring a check-off sheet for the ED that stimulates asking appropriate questions, including – "Has animal control been notified?" and suggesting the ED administer just the rabies vaccine for day 0 with the county health department to follow-up with human rabies immune globulin (must be given before day 7) if in fact the dog or cat is not available.
Please email your comments about this problem and suggestions for improvement to
lisa_conti@doh.state.fl.us.For information about rabies in Florida, please see the Bureau of Epidemiology website at: http://www.doh.state.fl.us/disease_ctrl/epi/htopics/popups/rabies.htm
4. Weekly Disease Table (Week 14)
| DISEASE |
1999 TO |
2000 TO |
3-YEAR |
2000 |
2001 TO |
2001 |
|
Animal Rabies |
40 |
33 |
45 |
161 |
56 |
7 |
|
Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, foodborne |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, infant |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, wound |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, other |
0 |
0 |
0 |
0 |
0 |
0 |
|
Brucellosis |
0 |
0 |
0.3 |
2 |
1 |
0 |
|
Campylobacteriosis |
181 |
169 |
161.3 |
1025 |
157 |
22 |
|
Ciguatera |
0 |
0 |
0 |
14 |
0 |
0 |
|
Cryptosporidiosis |
16 |
10 |
16.3 |
180 |
17 |
2 |
|
Cyclosporiasis |
0 |
1 |
1 |
9 |
21 |
0 |
|
Dengue Fever |
1 |
0 |
0.7 |
5 |
1 |
0 |
|
Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
|
Ehrlichiosis, human |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, chickenpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, herpes |
2 |
1 |
2 |
7 |
0 |
0 |
|
Encephalitis, influenza |
0 |
1 |
0.3 |
1 |
0 |
0 |
|
Encephalitis, measles |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, mumps |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, other |
1 |
1 |
0.7 |
8 |
1 |
0 |
|
Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Venezuelan |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Western Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Escherichia Coli 0157:H7 |
9 |
7 |
6.3 |
96 |
5 |
1 |
|
Escherichia Coli, other |
6 |
2 |
3.3 |
14 |
1 |
0 |
|
Giardiasis |
193 |
208 |
216.7 |
1466 |
170 |
22 |
|
H. Influenzae Cellulitis |
0 |
0 |
0.3 |
1 |
0 |
0 |
|
H. Influenzae Epiglottitis |
0 |
0 |
0 |
1 |
0 |
0 |
|
H. Influenzae Meningitis |
5 |
1 |
3.3 |
11 |
3 |
0 |
|
H. Influenzae Pneumonia |
2 |
2 |
2.3 |
8 |
8 |
0 |
|
H. Influenzae Prim.Bacteremia |
3 |
12 |
7 |
57 |
26 |
2 |
|
H. Influenzae Septic Arthritis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Hantaviris Infection |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hemolytic Uremic Syndrome |
1 |
2 |
1 |
17 |
1 |
0 |
|
Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hepatitis A |
147 |
128 |
136.3 |
592 |
138 |
9 |
|
Hepatitis B |
72 |
76 |
70.7 |
528 |
78 |
10 |
|
Hepatitis B (+HbsAg in pregnant women) |
5 |
61 |
22 |
493 |
60 |
5 |
|
Hepatitis, Perinatal Hep B |
0 |
0 |
0 |
1 |
1 |
1 |
|
Hepatitis C |
7 |
4 |
3.7 |
21 |
5 |
1 |
|
Hepatitis, Non-A, Non-B |
0 |
3 |
7 |
6 |
1 |
0 |
|
Hepatitis, Other, including unspecified |
2 |
4 |
2 |
7 |
3 |
0 |
|
Lead Poisoning |
359 |
278 |
336 |
1223 |
133 |
17 |
|
Legionellosis |
6 |
11 |
9.7 |
52 |
8 |
0 |
|
Leprosy |
0 |
0 |
0.7 |
4 |
0 |
0 |
|
Leptospirosis |
0 |
0 |
0 |
2 |
0 |
0 |
|
Listeriosis |
5 |
6 |
3.7 |
32 |
6 |
0 |
|
Lyme Disease |
2 |
2 |
3 |
55 |
0 |
0 |
|
Malaria |
20 |
13 |
15.7 |
90 |
11 |
0 |
|
Measles |
1 |
0 |
0.7 |
2 |
0 |
0 |
|
Meningitis, Group B Strep |
5 |
5 |
4 |
21 |
3 |
1 |
|
Meningitis, List Monocytogenes |
2 |
1 |
1.7 |
7 |
0 |
0 |
|
Meningitis, Meningococcal |
13 |
8 |
11 |
41 |
26 |
0 |
|
Meningitis, other |
14 |
21 |
15.3 |
110 |
10 |
0 |
|
Meningitis, Strep Pneumoniae |
37 |
38 |
37 |
110 |
22 |
0 |
|
Meningococcemia, disseminated |
20 |
23 |
24.7 |
81 |
15 |
0 |
|
Mercury Poisoning |
1 |
1 |
0.7 |
11 |
0 |
0 |
|
Mumps |
1 |
0 |
1 |
4 |
0 |
0 |
|
Neurotoxic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
|
Pertussis |
7 |
7 |
8.3 |
48 |
4 |
0 |
|
Plague, Bubonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Plague, Pneumonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Psittacosis |
0 |
0 |
0 |
3 |
0 |
0 |
|
Q Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Human Rabies |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rocky Mountain Spotted Fever |
1 |
0 |
0.7 |
1 |
1 |
0 |
|
Rubella |
0 |
1 |
0.3 |
2 |
0 |
0 |
|
Rubella, Congenital |
0 |
0 |
0 |
1 |
0 |
0 |
|
Salmonellosis |
355 |
314 |
331 |
2756 |
341 |
31 |
|
Shigellosis |
338 |
302 |
308.7 |
1295 |
134 |
7 |
|
Smallpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GISA/VISA) |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GRSA/VRSA) |
0 |
0 |
0 |
0 |
0 |
0 |
|
Streptococcal Disease, Invasive Group A |
11 |
39 |
21 |
150 |
41 |
1 |
|
Streptococcus Pneumoniae, Invasive |
159 |
282 |
199 |
1149 |
328 |
34 |
|
Tetanus |
1 |
0 |
0.7 |
1 |
0 |
0 |
|
Toxoplasmosis |
3 |
2 |
3 |
12 |
0 |
0 |
|
Trichinosis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Tularemia |
0 |
0 |
0 |
0 |
0 |
0 |
|
Typhoid Fever |
15 |
1 |
7 |
12 |
2 |
0 |
|
Vibrio Alginolyticus |
2 |
1 |
1.3 |
15 |
0 |
0 |
|
Vibrio Cholerae Type 01 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Vibrio Cholerae Non-01 |
2 |
1 |
1.3 |
4 |
0 |
0 |
|
Vibrio Fluvialis |
1 |
0 |
0.3 |
2 |
0 |
0 |
|
Vibrio Hollisae |
1 |
3 |
1.7 |
3 |
0 |
0 |
|
Vibrio Mimicus |
1 |
1 |
0.7 |
2 |
0 |
0 |
|
Vibrio, other |
0 |
0 |
0 |
2 |
0 |
0 |
|
Vibrio Parahaemolyticus |
1 |
1 |
1 |
16 |
0 |
0 |
|
Vibrio Vulnificus |
2 |
0 |
1 |
13 |
0 |
0 |
|
Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |